However, deviating from recommended doses can lead to adverse effects and accidental overdoses
Tan from the inside out
Medicines that help manage serious long-term conditions often come with new questions, especially when they rise in popularity as quickly as Ozempic has
According to Novo Nordisk, a 64-week clinical trial with over 300 participants found that those with obesity or overweight who took the oral Wegovy pill once a day lost an average of 16.6% of their body weight for people who completed the trial, a similar amount to those who took the injectable form of Wegovy, which launched in 2021, on a weekly basis
The first readout, TRIUMPH-1 (obesity), was reported on 21 May 2026, with 28.3% mean weight loss at 80 weeks in the 12mg cohort (Pharmaceutical Journal)
The first Phase I trial of Brenipatide was completed in 2021, but no data has been published that I can find